Plasma osteopontin levels and adverse clinical outcomes after ischemic stroke

Osteopontin is implicated in atherosclerosis, and its expression is upregulated in response to brain injury. The aim of this study was to prospectively investigate the associations between plasma osteopontin levels and adverse clinical outcomes in ischemic stroke patients.

Source: Atherosclerosis - July 29, 2021 Category: Cardiology Authors: Zhengbao Zhu, Yan He, Mengyao Shi, Daoxia Guo, Kaixin Zhang, Liyun Ren, Yanbo Peng, Pinni Yang, Jing Chen, Yuhan Zang, Aili Wang, Tan Xu, Qunwei Li, Zhong Ju, Deqin Geng, Yonghong Zhang, Jiang He Source Type: research